Press "Enter" to skip to content

Vertex Pharmaceuticals expands into Duchenne gene therapy with new deals

Vertex Pharmaceuticals Inc said http://pdf.reuters.com/htmlnews/htmlnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20190606:nBw4wRKsa on Thursday it would acquire privately held Exonics Therapeutics for an upfront payment of $245 million and potential milestone payments of up to $750 million.

Original source: http://feeds.reuters.com/~r/reuters/INhealth/~3/0vuJ4FvJtJ4/vertex-pharmaceuticals-expands-into-duchenne-gene-therapy-with-new-deals-idINKCN1T72YK

Also Read:   French coronavirus 24-hour death toll under 30 for fourth day